This list is an analysis based on recent market events. It's not an investment recommendation.
About
Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including skin, hair, and nail care products, as well as dietary supplement for atherosclerosis prophylaxis. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. The company is developing 1-MNA, an anti-atherosclerosis drug which is under phase II clinical trial. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. is a subsidiary of Pelion S.A.
The current price of PHR.WA is zł3.3 PLN — it has increased by +0.92% in the past 24 hours. Watch Pharmena Sa stock price performance more closely on the chart.
What is Pharmena Sa stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pharmena Sa stocks are traded under the ticker PHR.WA.
What is Pharmena Sa market cap?▼
Today Pharmena Sa has the market capitalization of 36.76M
What is Pharmena Sa revenue for the last year?▼
Pharmena Sa revenue for the last year amounts to 3.15M PLN.
What is Pharmena Sa net income for the last year?▼
PHR.WA net income for the last year is -5.54M PLN.
Does Pharmena Sa pay dividends?▼
Yes, PHR.WA dividends are paid annual. The last dividend per share was 0.85 PLN. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Pharmena Sa have?▼
As of April 05, 2026, the company has 24 employees.